Hamilton Wealth’s BioNTech BNTX Stock Holding History

Hamilton Wealth’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,858	Closed	-$2.49M	–	107
2024 Q4	$2.49M	Sell	21,858 -1,141	-5%	-$130K	0.6%	36
2024 Q3	$2.73M	Buy	+22,999	New	+$2.11M	0.67%	38

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Hamilton Wealth's BNTX Position: Q1 2025 in Review

Hamilton Wealth sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 21,858 shares — an estimated $2.49M sold.

Hamilton Wealth first reported a position in BNTX in Q3 2024 and held it in 2 quarters. The position peaked at $2.73M in Q3 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

Hamilton Wealth reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
Hamilton Wealth sold 21,858 BioNTech shares in Q1 2025, an estimated $2.49M.
Hamilton Wealth first reported a position in BioNTech in Q3 2024 and held it in 2 quarters.
Hamilton Wealth's BioNTech position peaked at $2.73M in Q3 2024.
280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Hamilton Wealth's 13F filing for Q1 2025, filed 14 Nov 2025.